sábado, 17 de mayo de 2025

Retifanlimab-dlwr Wins Upfront Indication for Anal Cancer M. Alexander Otto, PA, MMSc May 16, 2025

https://www.medscape.com/viewarticle/retifanlimab-dlwr-wins-upfront-indication-anal-cancer-2025a1000cfr

No hay comentarios:

Publicar un comentario